The vaccination is recommended for
Higher vaccine dosage is required for immunosuppressed and hemodialysis patients since standard dosage has been found to be less likely to result in the necessary antibody levels for these patients.
The vaccination should ideally be tested in hemodialysis patients 1-2 months after the last vaccine dose to ensure effectiveness of the vaccine.
Annual antibody counts should be performed to ensure booster doses are administered as required.
Inactivated Influenza Vaccine
Live, Attenuated Influenza Vaccine – CONTRAINDICATED
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
13-Valent Pneumococcal Conjugate Vaccine (PCV13)
Disclaimer: The UCLA Health System cannot guarantee the accuracy of such information. The information is provided without warranty or guarantee of any kind. Please speak to your Physician before making any changes.